Leaflet DORZOLAMIDA/TIMOLOL BROWN & BURK 20mg / 5mg / ml ophthalmic drops solution

Product code:
W71453001
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
dorzolamide + timolol (glaucoma agent + beta blocker)
ATC
S01ED51 — Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

Precautions:

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Elderly warning

Older people may have an increased risk of side effects.

The combination of Dorzolamide + timolol is used for the treatment of glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Dorzolamide is a carbonic anhydrase inhibitor, and Timolol is a beta-blocker; together, they reduce intraocular pressure through complementary mechanisms.

The medication is available as eye drops and is usually administered twice daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.

Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, fatigue, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the administration instructions to ensure treatment effectiveness.

General data about DORZOLAMIDA/TIMOLOL BROWN & BURK 20mg / 5mg / ml

Substance:
dorzolamide + timolol
Date of latest medicines list:
01-12-2025
Product code:
W71453001
Concentration:
20mg / 5mg / ml
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
EUROFINS ANALYTICAL SERVICES HUNGARY - UNGARIA
Holder:
BROWN & BURK IR LIMITED - IRLANDA
Number:
15291/2024/01
Shelf life:
2 years-Dupa ambalare pentru comercializare;after the first opening of the bottle-28 days

Pharmaceutical forms available for dorzolamide + timolol